One health
Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
News
Green chemistry for sustainable personal care
A recent review examined microbial biosurfactants as sustainable alternatives to synthetic surfactants in shampoo formulations. The authors addressed the growing demand for environmentally friendly and dermatologically safe cleansing agents, and emphasized the need to transition from petrochemical-based ingredients such as sodium lauryl sulfate (SLS) to biodegradable biosurfactants.
Read story
NewsVaccine skepticism on social media can predict public health crises
Researchers have developed a new approach that could help public health officials predict where outbreaks might occur. By analyzing social media posts, the method identifies early signs of increasing vaccine skepticism — a warning signal that could emerge before any disease begins to spread.
NewsMicropores pave the way for infection research
Organ-on-a-chip technology often contains gels that imitate the 3D environment of our tissues - however, many of these gels are too dense, hindering the passage of microbes and immune cells, and movement is essential to recreate how infections really develop. In this study, the research team developed a new type of porous gel that solves this problem.
NewsTime to act and not react: how can the European Union turn the tide of antimicrobial resistance?
Despite determined efforts by countries and healthcare professionals, Europe is not on track to meet four of the five AMR targets set by the EU Council for 2030*, according to data released on EAAD.
More One Health
News
Apriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
NewsMedications change our gut microbiome in predictable ways
A study shows that many of the changes to the gut microbiome are driven by competition for nutrients – medications reduce certain bacterial populations and change the availability of nutrients, and the bacteria most able to capitalize on those changes are the ones to survive.
NewsWastewater from most countries favours non-resistant bacteria
Municipal wastewater contains a large range of excreted antibiotics and has therefore long been suspected to be a spawning ground for antibiotic-resistant bacteria. By testing the potential of untreated municipal wastewater from 47 countries to select for resistant E. coli, researchers show that while some samples indeed do so, most instead suppress them.
NewsHepatitis E virus from rats can also infect humans in individual cases – a new zoonotic pathogen?
It has only been known for a few years that humans can also be infected with a variant of the hepatitis E virus that is usually prevalent in rats. Following reports of individual cases, mainly from Hong Kong and Spain, the first infection with ratHEV has now also been described in a patient from Germany.
NewsSugar transporter discovery offers promising avenue for improving antibiotic efficacy
Scientists have recently demonstrated that aminoglycosides enter bacteria by using sugar transporters. They have also successfully doubled the number of transporters, even in the most resistant Escherichia coli strains, thus improving antibiotics’ penetration rate and efficacy.
NewsSingle-celled organisms found to have a more complex DNA epigenetic code than multicellular life
Researchers discovered that in more ‘primitive’ unicellular organisms, both the adenine and the cytosine bases are methylated. This would suggest that in some ways, these unicellular organisms are more complex than their multicellular peers.
NewsA new gateway to global antimicrobial resistance data
To support global AMR research, EMBL’s European Bioinformatics Institute (EMBL-EBI) has launched the AMR portal, a central hub that connects bacterial genomes, resistance phenotypes, and functional annotations, all in one place. The AMR portal ensures long-term availability, standardisation, and reusability of AMR data.
CareersSummer studentship: Megan investigates the mobile gene element that gives MRSA its clout
Megan Stenton reports back on her AMI-sponsored summer studentship which investigated the frequency of the SCCmec gene - a mobile gene element that houses the methicillin resistance gene - across members of the same species of Staphylococcus aureus.
NewsTraces of bacteria inside brain tumors may affect tumor behavior
Scientists have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets the stage for future studies seeking to improve treatment outcomes.
NewsNext-generation microbiome medicine may revolutionize the treatment of Parkinson’s and similar disorders
Scientists have engineered the probiotic bacterium Escherichia coli Nissle 1917 as a drug-delivery system that continuously produces and delivers the gold-standard Parkinson’s drug Levodopa, which is converted to dopamine in the brain. E. coli Nissle strain was chosen for its century-long record of safely treating gastrointestinal disorders in humans.
NewsStudy in Europe: monoclonal antibodies effectively prevent respiratory syncytial virus in infants
Data from Belgium, Portugal and Spain show that immunisation of children after birth reduced the risk of hospitalization due to RSV infection by almost 80%.
NewsWild birds are driving the current U.S. bird flu outbreak
Researchers traced the introduction and spread of highly pathogenic H5N1 viruses during the first 18 months in North America using genomic sequencing and migratory flyway analysis, discovering that the viruses were spread primarily by wild migrating birds.
NewsNew bioelectroceutical platform triggers dual cell death, reverses immunosuppression in colorectal cancer
Scientists have developed a new “microbial fuel cell” platform that integrates electrogenic bacteria with piezoelectric nanoparticles to cooperatively eradicate colorectal tumors, reverse immunosuppression, and remodel the gut microbiome.
NewsWomen are three times more likely than men to get severe long COVID: Here’s why
Researchers have identified a distinct immune signature in female long Covid patients versus male patients. They found evidence of ’gut leakiness’ in the women patients, including elevated blood levels of intestinal fatty acid binding protein, lipopolysaccharide, and the soluble protein CD14 — all signs of gut inflammation that can then trigger further systemic inflammation.
NewsEveryday levels of antibiotics in the environment may accelerate the global spread of resistance, new study finds
A new study shows that even very small amounts of antibiotics that commonly appear in soil, rivers, wastewater, and agricultural runoff may significantly accelerate the spread of antibiotic resistance genes among bacteria.
NewsProtecting infants against respiratory syncytial virus this winter — ECDC issues advice
ECDC has issued rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of RSV disease among infants through immunisation and to support intensified efforts to protect them from RSV across Europe.
NewsBiomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).
NewsExperts urge continued hepatitis B vaccine birth doses for newborns
In a new commentary, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth. Hepatitis B vaccines are safe and effective with over one billion doses administered worldwide.
NewsKorea University College of Medicine’s Vaccine Innovation Center selected as lead institution for 2025 Korea-ARPA-H Health Security Project
The Vaccine Innovation Center at Korea University College of Medicine has been selected as the lead institution for a health security research initiative under the Ministry of Health and Welfare’s “2025 Korea-ARPA-H Project.”